Abstract

Mutations in the OCRL gene are associated with both Lowe syndrome and Dent-2 disease. Patients with Lowe syndrome present congenital cataracts, mental disabilities and a renal proximal tubulopathy, whereas patients with Dent-2 disease exhibit similar proximal tubule dysfunction but only mild, or no additional clinical defects. It is not yet understood why some OCRL mutations cause the phenotype of Lowe syndrome, while others develop the milder phenotype of Dent-2 disease. Our goal was to gain new insights into the consequences of OCRL exonic mutations on pre-mRNA splicing. Using predictive bioinformatics tools, we selected thirteen missense mutations and one synonymous mutation based on their potential effects on splicing regulatory elements or splice sites. These mutations were analyzed in a minigene splicing assay. Results of the RNA analysis showed that three presumed missense mutations caused alterations in pre-mRNA splicing. Mutation c.741G>T; p.(Trp247Cys) generated splicing silencer sequences and disrupted splicing enhancer motifs that resulted in skipping of exon 9, while mutations c.2581G>A; p.(Ala861Thr) and c.2581G>C; p.(Ala861Pro) abolished a 5′ splice site leading to skipping of exon 23. Mutation c.741G>T represents the first OCRL exonic variant outside the conserved splice site dinucleotides that results in alteration of pre-mRNA splicing. Our results highlight the importance of evaluating the effects of OCRL exonic mutations at the mRNA level.

Highlights

  • Altered pre-mRNA splicing is currently recognized as the underlying cause of many hereditary diseases [1,2,3,4]

  • In many instances in which pre-mRNA splicing is affected by an exonic mutation, the exon that is involved appears to be weakly defined [1]

  • It is known that exonic splicing enhancers (ESEs) elements are commonly present in exons with weak splice sites [35]

Read more

Summary

Introduction

Altered pre-mRNA splicing is currently recognized as the underlying cause of many hereditary diseases [1,2,3,4]. In addition to their protein coding potential, exonic sequences are involved in the regulation of pre-mRNA splicing. Exons may contain splicing regulatory elements such as exonic splicing enhancers (ESEs) and exonic splicing silencers (ESSs) that promote or inhibit the recognition of the neighboring splice sites, respectively [1]. The last three positions and the first two in the exons are an integral part of the 50 and 30 splice sites consensus sequences, respectively. Exonic mutations may affect splicing by altering regulatory elements, by abolishing or reducing the strength of the splice sites, or by creating new splice sites [1,5].

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call